Opko to list in Tel Aviv as part of Prolor purchase

|By:, SA News Editor

Opko Health (OPK) plans to register its shares on the Tel Aviv Stock Exchange as part of its $540M acquisition of Israeli drugmaker Prolor Biotech.

The move, which will add to Opko's listing on the NYSE, will enable the company to pay for the purchase with locally listed stock.

Opko's shares will start trading on the TASE on Wednesday. In October, the stock will enter the Tel Aviv 25 index of bluechip shares. (PR)